Author

Mattia Parisi

Institution: Ospedale di Rivoli

Observed institutions: Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Ospedale di Rivoli, University of Turin

ORCID: 0000-0002-5506-121X

Observed ORCID: 0000-0002-5506-121X

OpenAlex ID: A5054998593

Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up

2022 · Mattia Parisi, Irene Dogliotti, et al. · European Journal of Neurology · 21

Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection

2021 · Federico Piazza, Marco Bozzali, et al. · Neurological Sciences · 11

Longitudinal Assessment of Botulinum Toxin Treatment for Lateral Trunk Flexion and Pisa Syndrome in Parkinson’s Disease: Real-life, Long-Term Study

2023 · Claudia Ledda, Elisa Panero, et al. · Toxins · 8

Long Term Follow-up of Rituximab for Anti-Myelin-Associated Glycoprotein Demyelinating Polyneuropathy in IgM Gammopathies: Clinical, Hematological and Neurophysiological Correlations

2024 · Enrico Amaducci, Irene Dogliotti, et al. · Blood

A patient with demyelinating CMT carrying the p.Y347C heterozygous variant of the MME gene and the p.L131F heterozygous variant of the HARS1 gene

2022 · Mattia Parisi, Antonio Canosa, et al. · Neurological Sciences

Works count: 5

Citation count: 40

H-index: 3

I10-index: 2